Pharma 6.1 Immunosuppression and Rheumatoid Arthritis Flashcards Preview

ESA 5 > Pharma 6.1 Immunosuppression and Rheumatoid Arthritis > Flashcards

Flashcards in Pharma 6.1 Immunosuppression and Rheumatoid Arthritis Deck (23)
Loading flashcards...
1
Q

Describe the pathogenesis of rheumatoid arthritis

A
  • Inflammation of synovium of joints caused by T cells and macrophages.
  • Macrophages release cytokines IL-1, IL-8, and TNF-alpha which results in inflammation and synovitis..
  • Osteoblasts and fibroblasts activated to produce metalloproteinases
  • Synovium thickens and joint effusions. Inflamed synovium becomes known as apannus.
  • Pannus damages underlying cartilage, exposing bone.
2
Q

Describe the presentation of Rheumatoid arthritis

A
  • Symmetrical
  • Warm, tender joints with swelling
  • fixed flexion (boutonniere) or fixed hyperextension (swan neck) deformities
  • Pain and stiffness worse in mornings
3
Q

What type of drugs can be used to treat RA?

A

At first, DMARDs - Halt and reverse underlying processes

NSAIDs - reduce symptoms

Immunosuppressants

4
Q

Describe how methotrexate works in non malignant disease such as RA

A
  • Methotrexate inhibits enzymes involved in purine metabolism, leading to increased adenosine in cell.
  • Adenosine acts on GPCRs of inflammatory and immune cells leading to a reduced activity of T cells.
5
Q

How is methotrexate administered? How many times a day?

A

oral, Subcutaneous or intramuscular

Administered once a week!!

6
Q

What is the half life of methotrexate?

A

8-10 hours.

7
Q

How is methotrexate excreted?

A

renally

8
Q

Name 3 ADRs of methotrexate

A

myelosuppression, hepatitis, teratogenic, abortifactant.

9
Q

How is methotrexate monitored?

A

Baseline CXRs, FBCs (for myelosuppression), LFTs (hepatic damage), and U&Es and creatinine for renal function

10
Q

What is the mechanism of action of sulfasalazine in treating RA? What type of drug is it?

A
  • Inhibits T-cell proliferation and IL-2 production
  • DMARD
11
Q

What are the possible ADRs of sulfasalazine?

A

Nausea, fatigue, headaches

Myelosuppression, hepatitis

12
Q

Describe how azothioprine can be used to treat RA.

A
  • Metabolised to 6-MP which inhibits purine synthesis
  • Reduces therefore DNA and RNA synthesis.
  • Acts on cells with high mitotic rates
13
Q

How does azothioprine treatment differ from patient to patient?

A
  • TPMT enzyme eliminates 6-MP
  • TPMT subject to genetic polymorphism, differing levels produced by different patients.
14
Q

What are the ADRs of azothiprine

A

myelosuppression, increased risk of infection, emergence of malignant cell lines.

15
Q

How do corticosteroids work?

A

Inhibitors of gene expression

16
Q

How does cyclophosphamide work?

A
  • Forms DNA crosslinks between and within DNA strands, preventing replication.
  • Acts on cells with higher mitotic rates
17
Q

What are the ADRs of cyclophosphamide?

A

Leukaemia, infertitlity, teratogenesis, bladder cancer

18
Q

How is cyclophospahmide excreted?

A

Renally

19
Q

How does mycophenolate mofetil work?

A
  • Inhibits enzyme required for guanine synthesis
  • Resulting in impaired B and T cell proliferation whilst sparing other rapidly dividing cells.
20
Q

What are the ADRs of mycophenolate mofetil?

A

myelosuppression, increased risk of infection, nausea, vomiting, diarrhoea.

21
Q

Name 2 calcineurin inhibitors.

A

Tacrolimus and ciclosporin

22
Q

How do calcineurin inhibitors work?

A
  • Prevent IL-2 production by T helper cells by inhibiting calcineurin.
  • Ciclosporin binds to cyclophilin. Tacrolimus binds to Tacrolimus-binding protein. These complexes then bind to calcineurin.
23
Q

Name the ADRs of calcineurin inhibitors

A

nephrotoxicity, hypertension, hyperlipidaemia, nausea, vomiting (hyperesis), diarrhoea, hyperuricemia.